National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 2) (PB 22 of 2017) (Cth)

PB 22 of 2017

National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 2)

National Health Act 1953

I, KAREN BINNEKAMP, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated       30  March 2017

KAREN BINNEKAMP

Assistant Secretary (Acting)

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 2).

(2)   This Determination may also be cited as PB 22 of 2017.

1. Commencement

This Determination commences on 1 April 2017.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Abacavir

Omit

Abatacept

[2]     Schedule 1, after item dealing with Clodronic acid

Omit

Clonidine

[3]     Schedule 1, after item dealing with Coal tar-prepared

Insert

Cobimetinib

[4]     Schedule 1, after item dealing with Ferric carboxymaltose

Insert

Ferrous fumarate

[5]    Schedule 1, after item dealing with Glycomacropeptide and essential             

amino acids with vitamins and minerals

Insert

Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaeonic acid and low in phenylalanine

[6]    Schedule 1, after item dealing with Nafarelin

Omit

Naloxone

[7]   Schedule 1, after item dealing with Pazopanib

Omit

Pegfilgrastim

[8]   Schedule 1, after item dealing with Vedolizumab

Insert

Vemurafenib

[9]   Schedule 1, after item dealing with Vinblastine

Insert

Vismodegib

[10]   Schedule 2,

Insert as first item

Abatacept

[11]   Schedule 2, after item dealing with Clonazepam

Insert

Clonidine

[12]   Schedule 2, after item dealing with Esomeprazole and clarithromycin and

amoxycillin

Insert

Etanercept

[13]   Schedule 2, after item dealing with Mycophenolic acid

Insert

Naloxone

[14]   Schedule 2, after item dealing with Paroxetine

Insert

Pegfilgrastim